Table 3.
Studies exploring respiratory infections or studies exploring wheezing in the context of respiratory infections
Age at gut microbiota determination | Diversity (respiratory disease vs non-respiratory disease) | Relative abundance of bacteria taxa (fungal taxa) in respiratory disease versus non-respiratory disease | Age of participants at respiratory disease determination (outcome) | AHRQ rating | |
---|---|---|---|---|---|
Reyman et al (2019)33 | ≤1 month | Not reported | Lower Bifidobacterium; higher Klebsiella and Enterococcus | 1 year (cumulative incidence of respiratory infections) | Good |
Arrieta et al (2015)27 | 3 months | No difference | No difference | 1 year (wheezing) | Poor |
Boutin et al (2020)35 | 3 months | α-diversity decreased | Lower Faecalibacterium, Lachnospira, Coprococcus, and Oscillospira | 1 year (recurrent wheezing) | Poor |
Laursen et al (2015)28 | 9 months | No difference | No difference | 3 years (wheezing in respiratory infection context) | Poor |
Arrieta et al (2015)27 | 1 year | No difference | No difference | 1 year (wheezing) | Poor |
AHRQ=Newcastle-Ottawa Quality assessment for cohort and case-control studies converted to the Agency for Healthcare Research and Quality scale.